Truist lowered the firm’s price target on Lantheus (LNTH) to $120 from $135 and keeps a Buy rating on the shares after its Q3 results. Given that pricing and share loss headwinds have already begun to impact Q3 and Q4, plus the still lingering uncertainty around CMS’s final 2025 payment for Pylarify, the lack of a firm commitment from the management around Pylarify growth in 2025 added uncertainty as to whether pricing headwinds into next year might be worse-than-feare, the analyst tells investors in a research note. Truist adds however that it still believes in Pylarify 2025 growth.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH:
- Lantheus price target lowered to $112 from $125 at JMP Securities
- Lantheus Reports Strong Q3 2024 Revenue Growth
- Lantheus price target lowered to $123 from $137 at JonesResearch
- Lantheus reports Q3 adjusted EPS $1.70, consensus $1.56
- Lantheus narrows FY24 adjusted EPS view to $6.65-$6.70 from $6.60-$6.70